Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001493152-23-020567
Filing Date
2023-06-08
Accepted
2023-06-08 16:15:53
Documents
10

Document Format Files

Seq Description Document Type Size
1 formf-3.htm F-3 578681
2 ex5-1.htm EX-5.1 67943
3 ex23-1.htm EX-23.1 7636
4 ex107.htm EX-FILING FEES 21221
5 formf-3_001.jpg GRAPHIC 9324
6 formf-3_002.jpg GRAPHIC 32992
7 ex5-1_001.jpg GRAPHIC 29582
8 ex5-1_002.jpg GRAPHIC 15121
9 ex5-1_003.jpg GRAPHIC 3217
10 ex23-1_001.jpg GRAPHIC 10346
  Complete submission text file 0001493152-23-020567.txt   815598
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: F-3 | Act: 33 | File No.: 333-272516 | Film No.: 231002105
SIC: 2836 Biological Products, (No Diagnostic Substances)